Total Payments
$15,127
2024 Payments
$5,676
Companies
52
Transactions
587
Medicare Patients
99
Medicare Billing
$10,439
Payment Breakdown by Category
Food & Beverage$12,396 (81.9%)
Education$1,634 (10.8%)
Other$1,097 (7.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,396 | 559 | 81.9% |
| Education | $1,634 | 17 | 10.8% |
| Long term medical supply or device loan | $1,097 | 11 | 7.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,712 | 51 | $0 (2024) |
| Lilly USA, LLC | $1,143 | 47 | $0 (2024) |
| Incyte Corporation | $975.69 | 30 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $937.96 | 26 | $0 (2024) |
| Daiichi Sankyo Inc. | $890.77 | 34 | $0 (2024) |
| Seagen Inc. | $859.70 | 29 | $0 (2023) |
| Janssen Biotech, Inc. | $825.32 | 29 | $0 (2024) |
| Merck Sharp & Dohme LLC | $786.08 | 25 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $747.07 | 76 | $0 (2024) |
| PFIZER INC. | $711.13 | 32 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,676 | 182 | Novartis Pharmaceuticals Corporation ($1,197) |
| 2023 | $3,933 | 169 | Lilly USA, LLC ($324.71) |
| 2022 | $2,927 | 117 | Seagen Inc. ($441.40) |
| 2021 | $2,591 | 119 | Lilly USA, LLC ($363.44) |
All Payment Transactions
587 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Janssen Biotech, Inc. | TALVEY (Biological), TECVAYLI, DARZALEX | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $27.34 | General |
| Category: Hematology | ||||||
| 12/09/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $36.16 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/06/2024 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $24.76 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.62 | General |
| 12/06/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $17.86 | General |
| 12/06/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $16.89 | General |
| 12/06/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $2.23 | General |
| 12/03/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $30.84 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Genetically Defined Disease | ||||||
| 11/26/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $1.56 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $10.22 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $1.50 | General |
| Category: Oncology | ||||||
| 11/16/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 11/09/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $122.76 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Genetically Defined Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 43 | 68 | $19,460 | $4,508 |
| 2022 | 1 | 19 | 29 | $8,390 | $2,212 |
| 2021 | 2 | 22 | 38 | $9,722 | $2,275 |
| 2020 | 1 | 15 | 35 | $7,665 | $1,444 |
Total Patients
99
Total Services
170
Medicare Billing
$10,439
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 55 | $16,510 | $3,842 | 23.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 13 | $2,950 | $666.38 | 22.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 29 | $8,390 | $2,212 | 26.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 24 | $5,256 | $1,217 | 23.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 14 | $4,466 | $1,058 | 23.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 35 | $7,665 | $1,444 | 18.8% |
About Christina Lao
Christina Lao is a Family healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2016. The National Provider Identifier (NPI) number assigned to this provider is 1427502681.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christina Lao has received a total of $15,127 in payments from pharmaceutical and medical device companies, with $5,676 received in 2024. These payments were reported across 587 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($12,396).
As a Medicare-enrolled provider, Lao has provided services to 99 Medicare beneficiaries, totaling 170 services with total Medicare billing of $10,439. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Brooklyn, NY
- Active Since 08/04/2016
- Last Updated 08/04/2016
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1427502681
Products in Payments
- KISQALI (Drug) $1,190
- KEYTRUDA (Biological) $786.08
- Enhertu (Drug) $762.59
- VERZENIO (Drug) $745.57
- Lenvima (Drug) $673.60
- MONJUVI (Drug) $524.26
- OPDIVO (Biological) $451.62
- REBLOZYL (Biological) $431.28
- PROMACTA (Drug) $372.01
- ENHERTU (Biological) $370.21
- DARZALEX (Biological) $349.74
- PADCEV (Biological) $329.48
- BRUKINSA (Drug) $275.00
- ERLEADA (Drug) $262.99
- VOQUEZNA (Drug) $250.00
- TUKYSA (Drug) $231.03
- LONSURF (Drug) $230.72
- JAKAFI (Drug) $215.93
- JEVTANA (Drug) $212.29
- IBRANCE (Drug) $188.75
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Brooklyn
Susan Weiss, Np, NP
Family — Payments: $20,923
Family $20,923
Ms. Abigail Hunter, Fnp, FNP
Family — Payments: $18,034
Family $18,034
Seida Velija
Family — Payments: $15,903
Family $15,903
Ami Lam
Family — Payments: $15,616
Family $15,616
Mrs. Kelly Morris, Fnp, FNP
Family — Payments: $8,415
Family $8,415
Lorraine Bertelle, Family Nurse Practit, FAMILY NURSE PRACTIT
Family — Payments: $7,053
Family $7,053